2017
DOI: 10.18632/oncotarget.22319
|View full text |Cite
|
Sign up to set email alerts
|

Baicalein suppresses the androgen receptor (AR)-mediated prostate cancer progression via inhibiting the AR N-C dimerization and AR-coactivators interaction

Abstract: BackgroundAndrogen receptor (AR) plays a critical role in prostate cancer (PCa) development and progression. Androgen deprivation therapy with antiandrogens to reduce androgen biosynthesis or prevent androgens from binding to AR are widely used to suppress AR-mediated PCa growth. However, most of ADT may eventually fail with development of the castration resistance after 12-24 months. Here we found that a natural product baicalein can effectively suppress the PCa progression via targeting the androgen-induced … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
13
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 50 publications
1
13
0
Order By: Relevance
“…Betulinic acid and bevirimat are also showed potential to inhibit serine protease-2 activity, and these compounds may be potential to use against SARS-CoV-2 because of their anti -HIV properties. Baicalein is known to suppress the androgen receptor (AR) target genes like TMPRSS2 in prostate cancer (PCa) progression, 63 and its effective binding with at the active site can be a potential target to use against COVID-19. Hesperidin is a flavone glycoside that showed a similar binding characteristic to nafamostat, a TMPRSS2 inhibitor.…”
Section: Resultsmentioning
confidence: 99%
“…Betulinic acid and bevirimat are also showed potential to inhibit serine protease-2 activity, and these compounds may be potential to use against SARS-CoV-2 because of their anti -HIV properties. Baicalein is known to suppress the androgen receptor (AR) target genes like TMPRSS2 in prostate cancer (PCa) progression, 63 and its effective binding with at the active site can be a potential target to use against COVID-19. Hesperidin is a flavone glycoside that showed a similar binding characteristic to nafamostat, a TMPRSS2 inhibitor.…”
Section: Resultsmentioning
confidence: 99%
“…Except the well-documented flutamide, new chemicals appear to show therapeutic effects on prostate cancer cells. In our previous study [10, 11], Cryptotanshinone and Baicalein, structures of which are similar to DHT, were found to suppress androgen receptor-mediated growth in androgen-dependent prostate cancer cells. The structure of kaempferol, similar to Cryptotanshinone or Baicalein, is very close to DHT too (Figure 1).…”
Section: Discussionmentioning
confidence: 99%
“…Refer to the method in our previous studies [10, 11]. In brief, HEK293 and LNCaP cells lacking of functional AR were transfected with wild-type AR expression plasmid and reporter genes such as pSG5-AR, pSG5-PR, pSG5-GR, MMTV-Luc, and pRL-TK-luc for AR for 24 h. Then, the cells were cocultured with various concentrations of kaempferol in the presence or absence of 1 nM dihydrotestosterone (DHT) (Sigma, USA) and/or 5 μ M hydroxyflutamide (HF) (Sigma, USA) for 24 h. The cells were harvested and assayed for luciferase activity.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations